Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Wallerian axonal degeneration (WD) does not occur in the nematode C. elegans, in contrast to other model animals. However, WD depends on the NADase activity of SARM1, a protein that is also expressed in C. elegans (ceSARM/ceTIR-1). We hypothesized that differences in SARM between species might exist and account for the divergence in WD. We first show that expression of the human (h)SARM1, but not ceTIR-1, in C. elegans neurons is sufficient to confer axon degeneration after nerve injury. Next, we determined the cryoelectron microscopy structure of ceTIR-1 and found that, unlike hSARM1, which exists as an auto-inhibited ring octamer, ceTIR-1 forms a readily active 9-mer. Enzymatically, the NADase activity of ceTIR-1 is substantially weaker (10-fold higher Km) than that of hSARM1, and even when fully active, it falls short of consuming all cellular NAD. Our experiments provide insight into the molecular mechanisms and evolution of SARM orthologs and WD across species.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675840PMC
http://dx.doi.org/10.1016/j.celrep.2023.113026DOI Listing

Publication Analysis

Top Keywords

wallerian axonal
8
axonal degeneration
8
nadase activity
8
structure-function analysis
4
analysis cetir-1/hsarm1
4
cetir-1/hsarm1 explains
4
explains lack
4
lack wallerian
4
elegans
4
degeneration elegans
4

Similar Publications

Previous data on the time course of corticospinal tract (CST) degeneration after stroke are scarce, especially in the early phase. Using post-mortem histomorphological and immunohistochemical methods, CST degeneration (its temporal dynamics and its association with stroke type) was investigated in the medulla oblongata pyramids in twenty-two cases: nine patients with ischemic stroke and eleven with hemorrhagic stroke and two patients with very long survival after multiple strokes. CD68 and neurofilament immunohistochemistry and Klüver-Barrera staining were applied to assess microglial activation and axonal and myelin degeneration, respectively, and statistical methods were used to investigate the relationship between microglial density, stroke type, and survival time.

View Article and Find Full Text PDF

Cryoneurolysis as a Neuroregenerative Intervention for Chronic Painful Mononeuropathies: A Four-Patient Case Series and Discussion.

Cardiovasc Intervent Radiol

August 2025

Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia.

Posttraumatic painful mononeuropathy involves a permanent structural change in the affected nerve. Clinical and animal models have shown that exposure of nerves to specific cold temperatures for distinct time periods can induce: cessation of signal transduction, Wallerian degeneration, and predictable axonal regeneration. It is hypothesized that these processes may return a structurally altered painful nerve to a non-pathologic or normal state.

View Article and Find Full Text PDF

Glioblastoma (GBM) is an aggressive and highly therapy-resistant brain tumour. Although advanced disease has been intensely investigated, the mechanisms that underpin the earlier, likely more tractable, stages of GBM development remain poorly understood. Here we identify axonal injury as a key driver of GBM progression, which we find is induced in white matter by early tumour cells preferentially expanding in this region.

View Article and Find Full Text PDF

Background: Charcot-Marie-Tooth (CMT) disease can be caused by mutations in over 100 different genes, most of which lead to demyelination (type 1) or degeneration (type 2) of peripheral motor and sensory axons. SARM1 is a protein involved in the active process of Wallerian degeneration after axonal injury. Inhibition of SARM1 protects against axon degeneration following injury or in cases such as chemotherapy-induced peripheral neuropathy.

View Article and Find Full Text PDF

Background: Degeneration of peripheral motor and sensory axons is a key aspect of the pathophysiology of Charcot-Marie-Tooth disease and related inherited neurodegenerative conditions.

Aims: Given that mutations in many (> 100) genes can cause these disorders, it is unclear if a generalized therapeutic strategy can be identified that will apply across these disease subtypes; however, strategies to prevent or slow axon degeneration are attractive candidates. Wallerian axon degeneration is an active process following insults such as nerve injury, and SARM1 is a central mediator of this process.

View Article and Find Full Text PDF